发明名称 Lipids, lipid compositions, and methods of using them
摘要 Disclosed are formulation and optimization protocols for delivery of therapeutically effective amounts of biologically active agents to liver, tumors, and/or other cells or tissues. Also provided are compositions and uses for cationic lipid compounds of formula (I).; The invention also relates to compositions and uses for stealth lipids of formula (XI). ; Also provided are processes for making such compounds, compositions, and formulations, plus methods and uses of such compounds, compositions, and formulations to deliver biologically active agents to cells and/or tissues.
申请公布号 US9301923(B2) 申请公布日期 2016.04.05
申请号 US201414197124 申请日期 2014.03.04
申请人 NOVARTIS AG 发明人 Baryza Jeremy;Bowman Keith;Geall Andrew;Labonte Tanzina;Lee Cameron;Vargeese Chandra;West Laura;Zhao Junping
分类号 A61K31/575;A61K47/06;A61K9/127;A61K31/7088;A61K47/18;A61K47/28;A61K47/30;C07J9/00;C07J41/00;C07J43/00;A61K47/14;C07J31/00 主分类号 A61K31/575
代理机构 Brinks Gilson & Lione 代理人 Brinks Gilson & Lione
主权项 1. A stealth lipid of formula (XI)or a salt or pharmaceutically acceptable derivative thereof,wherein: Z is a hydrophilic head group component selected from PEG and polymers based on poly(oxazoline), poly(ethyleneoxide), poly(vinyl alcohol), poly(glycerol), poly(N-vinylpyrrolidone), poly[N-(2-hydroxypropyl)methacrylamide] and poly(amino acid)s, wherein the polymer may be linear or branched, and wherein the polymer may be optionally substituted; wherein Z is polymerized by n subunits; n is a number-averaged degree of polymerization between 10 and 200 units of Z, wherein n is optimized for different polymer types; L1 is an optionally substituted C1-10 heteroalkylene linker including one, two or more of an ester (e.g., —C(O)O—), succinate (e.g., —O(O)C—CH2—CH2—C(O)O—)), carbamate (e.g., —OC(O)—NR′—), carbonate (e.g., —OC(O)O—), ketone (e.g., —C—C(O)—C—), carbonyl (e.g., —C(O)—), urea (e.g., —NRC(O)NR′—), amine (e.g., —NR′—), amide (e.g., —C(O)NR′—), imine (e.g., —C(NR′)—), thioether (e.g., —S—), xanthate (e.g., —OC(S)S—), and phosphodiester (e.g., —OP(O)2O—); any of which may be substituted by zero, one or more Z groups; wherein R′ is independently selected from —H, —NH—, —NH2, —O—, —S—, a phosphate or an optionally substituted C1-10 alkylene; X1 and X2 are independently selected from a carbon or a heteroatom selected from —NH—, —O—, —S— or a phosphate; and A1 and A2 are independently selected from a C6-30 alkyl, C6-30 alkenyl, and C6-30 alkynyl, wherein A1 and A2 may be the same or different.
地址 Basel CH
您可能感兴趣的专利